Ryogo Umetsu

633 total citations
21 papers, 467 citations indexed

About

Ryogo Umetsu is a scholar working on Toxicology, Pharmacology and Pharmacology. According to data from OpenAlex, Ryogo Umetsu has authored 21 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Toxicology, 5 papers in Pharmacology and 4 papers in Pharmacology. Recurrent topics in Ryogo Umetsu's work include Pharmacovigilance and Adverse Drug Reactions (12 papers), Pharmacy and Medical Practices (4 papers) and Drug-Induced Adverse Reactions (3 papers). Ryogo Umetsu is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (12 papers), Pharmacy and Medical Practices (4 papers) and Drug-Induced Adverse Reactions (3 papers). Ryogo Umetsu collaborates with scholars based in Japan, China and United States. Ryogo Umetsu's co-authors include Mitsuhiro Nakamura, Junko Abe, Yasutomi Kinosada, Yamato Kato, Natsumi Ueda, Yôko Nakayama, Toshinobu Matsui, Sayaka Sasaoka, Yumi Motooka and Haruna Hatahira and has published in prestigious journals such as PLoS ONE, Frontiers in Pharmacology and Biological and Pharmaceutical Bulletin.

In The Last Decade

Ryogo Umetsu

21 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryogo Umetsu Japan	13	168	110	77	55	51	21	467
Natsumi Ueda Japan	13	150 0.9×	111 1.0×	80 1.0×	40 0.7×	56 1.1×	24	468
Yamato Kato Japan	13	136 0.8×	105 1.0×	69 0.9×	44 0.8×	46 0.9×	25	423
Pipasha Biswas United Kingdom	10	137 0.8×	98 0.9×	44 0.6×	89 1.6×	59 1.2×	15	528
Fanny Rocher France	12	78 0.5×	60 0.5×	31 0.4×	34 0.6×	108 2.1×	58	547
Cindy Kortepeter United States	15	97 0.6×	117 1.1×	61 0.8×	45 0.8×	139 2.7×	30	787
Denyse Thornley‐Brown United States	12	125 0.7×	132 1.2×	21 0.3×	25 0.5×	26 0.5×	19	690
Ariola Koci Italy	10	76 0.5×	46 0.4×	60 0.8×	47 0.9×	25 0.5×	16	386
Yannick Arimone France	11	233 1.4×	110 1.0×	65 0.8×	93 1.7×	22 0.4×	11	572
Michele Fusaroli Italy	13	131 0.8×	67 0.6×	27 0.4×	38 0.7×	184 3.6×	45	562
Alexandre O. Gérard France	11	66 0.4×	54 0.5×	17 0.2×	26 0.5×	66 1.3×	37	475

Countries citing papers authored by Ryogo Umetsu

Since Specialization

Citations

This map shows the geographic impact of Ryogo Umetsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryogo Umetsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryogo Umetsu more than expected).

Fields of papers citing papers by Ryogo Umetsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryogo Umetsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryogo Umetsu. The network helps show where Ryogo Umetsu may publish in the future.

Co-authorship network of co-authors of Ryogo Umetsu

This figure shows the co-authorship network connecting the top 25 collaborators of Ryogo Umetsu. A scholar is included among the top collaborators of Ryogo Umetsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryogo Umetsu. Ryogo Umetsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Umetsu, Ryogo, Mizuki Tanaka, Yôko Nakayama, et al.. (2021). Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network. Frontiers in Pharmacology. 12. 764279–764279. 15 indexed citations

Nakao, Satoshi, Shiori Hasegawa, Ryogo Umetsu, et al.. (2021). Pharmacovigilance study of anti-infective-related acute kidney injury using the Japanese adverse drug event report database. BMC Pharmacology and Toxicology. 22(1). 8 indexed citations

Hasegawa, Shiori, et al.. (2018). Evaluation of pregabalin-induced adverse events related to falls using the FDA adverse event reporting system and Japanese Adverse Drug Event Report databases. Journal of Clinical Pharmacy and Therapeutics. 44(2). 285–291. 8 indexed citations

Motooka, Yumi, Toshinobu Matsui, Ryogo Umetsu, et al.. (2018). Adverse events of smoking cessation treatments (nicotine replacement therapy and non-nicotine prescription medication) and electronic cigarettes in the Food and Drug Administration Adverse Event Reporting System, 2004−2016. SAGE Open Medicine. 6. 2105849953–2105849953. 20 indexed citations

Abe, Junko, Ryogo Umetsu, Hiroaki Uranishi, et al.. (2017). Analysis of polypharmacy effects in older patients using Japanese Adverse Drug Event Report database. PLoS ONE. 12(12). e0190102–e0190102. 29 indexed citations

Matsui, Toshinobu, Ryogo Umetsu, Yamato Kato, et al.. (2017). Age-related trends in injection site reaction incidence induced by the tumor necrosis factor-α (TNF-α) inhibitors etanercept and adalimumab: the Food and Drug Administration adverse event reporting system, 2004-2015. International Journal of Medical Sciences. 14(2). 102–109. 24 indexed citations

Sasaoka, Sayaka, Haruna Hatahira, Shiori Hasegawa, et al.. (2017). Adverse Event Trends Associated with Over-the-counter Combination Cold Remedy: Data Mining of the Japanese Adverse Drug Event Report Database. YAKUGAKU ZASSHI. 138(1). 123–134. 7 indexed citations

Abe, Junko, Ryogo Umetsu, Yamato Kato, et al.. (2016). Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese Adverse Drug Event Report database. Journal of Pharmaceutical Health Care and Sciences. 2(1). 14–14. 71 indexed citations

Sasaoka, Sayaka, Toshinobu Matsui, Junko Abe, et al.. (2016). Evaluation of the Association of Hand-Foot Syndrome with Anticancer Drugs Using the US Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) Databases. YAKUGAKU ZASSHI. 136(3). 507–515. 18 indexed citations

10.

Motooka, Yumi, Ryogo Umetsu, Junko Abe, et al.. (2016). Evaluation of Hypoglycemia with Oral Hypoglycemic Agents by Using Spontaneous Adverse Event Reports Database. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 42(6). 416–428. 2 indexed citations

11.

Nakamura, Mitsuhiro, Ryogo Umetsu, Junko Abe, et al.. (2015). Analysis of the time-to-onset of osteonecrosis of jaw with bisphosphonate treatment using the data from a spontaneous reporting system of adverse drug events. Journal of Pharmaceutical Health Care and Sciences. 1(1). 34–34. 58 indexed citations

12.

Kato, Yamato, Ryogo Umetsu, Junko Abe, et al.. (2015). Hyperglycemic adverse events following antipsychotic drug administration in spontaneous adverse event reports. Journal of Pharmaceutical Health Care and Sciences. 1(1). 15–15. 26 indexed citations

13.

Abe, Junko, Ryogo Umetsu, Yamato Kato, et al.. (2015). Evaluation of Dabigatran- and Warfarin-Associated Hemorrhagic Events Using the FDA-Adverse Event Reporting System Database Stratified by Age. International Journal of Medical Sciences. 12(4). 312–321. 22 indexed citations

14.

Matsui, Toshinobu, Ryogo Umetsu, Yamato Kato, et al.. (2015). Adverse Event Signals of Interstitial Lung Disease in the FDA Adverse Event Reporting System (FAERS) Database and the Japanese Adverse Drug Event Report (JADER) Database. 17(3). 145–154. 4 indexed citations

15.

Umetsu, Ryogo, Junko Abe, Natsumi Ueda, et al.. (2015). Adverse Event Trends Associated with Over-the-counter Drugs: Data Mining of the Japanese Adverse Drug Event Report Database. YAKUGAKU ZASSHI. 135(8). 991–1000. 9 indexed citations

16.

Suzuki, Yukiya, Ryogo Umetsu, Hiroaki Uranishi, et al.. (2015). Analysis of the Interaction between Clopidogrel, Aspirin, and Proton Pump Inhibitors Using the FDA Adverse Event Reporting System Database. Biological and Pharmaceutical Bulletin. 38(5). 680–686. 54 indexed citations

17.

Umetsu, Ryogo, Junko Abe, Natsumi Ueda, et al.. (2015). Association between Selective Serotonin Reuptake Inhibitor Therapy and Suicidality: Analysis of U.S. Food and Drug Administration Adverse Event Reporting System Data. Biological and Pharmaceutical Bulletin. 38(11). 1689–1699. 36 indexed citations

18.

Kato, Yamato, Ryogo Umetsu, Naoki Hosoya, et al.. (2015). Analysis of licorice-induced pseudoaldosteronism in the Japanese Adverse Drug Event Report database. Traditional & Kampo Medicine. 3(1). 63–70. 12 indexed citations

19.

Umetsu, Ryogo, Natsumi Ueda, Yamato Kato, et al.. (2015). Analysis of the Association between Renin-Angiotensin System Blockers and Angioedema. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 41(8). 556–565. 3 indexed citations

20.

Umetsu, Ryogo, Junko Abe, Yukiya Suzuki, et al.. (2014). Evaluation of the Association between the Use of Oral Anti-hyperglycemic Agents and Hypoglycemia in Japan by Data Mining of the Japanese Adverse Drug Event Report (JADER) Database. YAKUGAKU ZASSHI. 134(2). 299–304. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact